| Lung Squamous Cell Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 58show all (up to 200) |
|---|
| → investigated in trials for | Docetaxelsmall molecule 18 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lung Squamous Cell Carcinoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 17 trials (6 active) · roll-up of the cancer and its descendants | — | — | Lung Squamous Cell Carcinoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 15 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lung Squamous Cell Carcinoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 10 trials (7 active) · roll-up of the cancer and its descendants | — | — | Lung Squamous Cell Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Squamous Cell Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Squamous Cell Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Squamous Cell Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Squamous Cell Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Squamous Cell Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Squamous Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fexagratinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Squamous Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gefitinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Squamous Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |